N@N

Clinical Data, Inc. to Present at the 22nd Annual Piper Jaffray Health Care Conference

^{Published on 2010-11-23 09:00:36 - Market Wire}
 

NEWTON, Mass.--([ BUSINESS WIRE ])--[ Clinical Data, Inc. ] ([ NASDAQ: CLDA ]), today announced that Drew Fromkin, President and Chief Executive Officer, will be presenting a Company overview at the 22^nd Annual Piper Jaffray Health Care Conference, November 30, 2010 at the New York Palace Hotel, New York, NY. Clinical Dataa™s presentation will take place at 2:00 p.m. EST.

A live audio and archived webcast of the Companya™s presentation can be accessed through Clinical Data's website at [ www.clda.com ].

About Clinical Data, Inc.

Clinical Data develops first-in-class and best-in-category therapeutics. The Company is advancing its late-stage drug candidates for [ central nervous system disorders ] and [ cardiovascular diseases ], to be followed by promising drug candidates in major therapeutic areas including [ oncology and inflammatory diseases ]. Clinical Data plans to differentiate its therapeutics by combining its drug development and biomarker expertise to develop products with enhanced efficacy and tolerability, improving patient health and reducing costs. To learn more, please visit the Company's website at [ www.clda.com ].